Highlighting two papers recently published from the Carr lab—including a collab with the Wu lab:
1. a mouse model of early metabolic + alcohol-assoc liver disease
pubmed.ncbi.nlm.nih.gov/3713…
@UWDIVGASTRO @NIAAAnews
2. a microbiome investigation of non-cirrhotic NASH vs healthy controls controlled for age and BMI
@UWDIVGASTRO @penngihep
pubmed.ncbi.nlm.nih.gov/3722…
Carr-Lab retweeted
The Redinbo Laboratory is searching for postdoctoral fellows with experience relevant to our mission of identifying drug targets in the gut microbiome. Expertise in microbiome investigations, animal model systems and proteomics, for example, are desirable.
Carr-Lab retweeted
Look who is on the front page @AASLDtweets Rotonya M. Carr, MD shar.es/aW0mBC #liver #NAFLD #ALD #livermetabolism #hepatology @blackingastro
Carr-Lab retweeted
Congratulations to @RotonyaC (@carr_lab) at @PennMedicine, a former @jlipidres junior associate editor, on being an inaugural recipient of the International Ceramide Committee's Lina Obeid Award for young investigators! #ASBMBMemberMonday @SL_Biology asbmb.org/asbmb-today/people…
Carr-Lab retweeted
NEW COMMENT! @drfolamay, @PascaleWhite, @realDoctorUgo & @RotonyaC on advancing health equity and the formation of The Association of Black Gastroenterologists and Hepatologists
go.nature.com/3vZ8zhR
@blackingastro #blackingastro
Carr-Lab retweeted
NEW! REVIEW The complex link between #NAFLD and type 2 #diabetes mellitus — mechanisms and treatments
By Giovanni Targher, Kathleen Corey, Christopher Byrne & Michael Roden
go.nature.com/3o9mlvA
#MAFLD #obesity
Ceramides’ role in liver disease asbmb.org/asbmb-today/scienc… #NAFLD #cearmide #steatosis #liverdisease #ALD #lipiddroplet @ASBMB
Carr-Lab retweeted
Ceramides’ role in liver disease asbmb.org/asbmb-today/scienc… @ASBMB #NAFLD #ALD #ceramide #steatosi #liverdisease #fattyliver
Carr-Lab retweeted
#ASBMB2021: We're looking forward to our annual meeting next month! One event we'd like to highlight is the @jlipidres spotlight session featuring JLR junior associate editors @BlindLab, @carr_lab, Brandon Davies & Gissette Reyes–Soffer. Learn more: asbmb.org/asbmb-today/people….
Carr-Lab retweeted
Importantly, the @ScienceTM paper also outlines proposed strategies for academic medical centers to address needs & reverse these losses, including ways to bolster the careers of URM researchers affected by the pandemic. stm.sciencemag.org/content/1…
Carr-Lab retweeted
The authors note how mitigating the impact of COVID on research & supporting #URM researchers' careers will improve conditions for everyone. @RotonyaC @DrRoyHamilton @mlanefall @Risalavizzo @bradylabupenn @GDalembert @DrDianaMW @GuerraViswanath @Eugenia_South Florence Momplaisir
Carr-Lab retweeted
#COVID19 halted research operations at academic medical centers across the U.S. one year ago. In a new @ScienceTM paper, @PennMedicine experts led by @RotonyaC outlined how the pandemic impacted research & disproportionately affected #URM researchers. stm.sciencemag.org/content/1…
Carr-Lab retweeted
New content online: Nonalcoholic fatty liver disease: another leap forward dlvr.it/Rq9hYB
Carr-Lab retweeted
The Best of The Liver Meeting 2020 slides are now available for download! Head over to LiverLearning to access this great content: liverlearning.aasld.org/reso…
#TLMdX #LiverLearning #LiverTwitter
Carr-Lab retweeted
Today, for our countdown to GOLD #openaccess, we have a short message from @RotonyaC, @carr_lab, a junior associate editor for @jlipidres.
Carr-Lab retweeted
Meet @jlipidres junior associate editors @BlindLab, @carr_lab, Brandon Davies and Gissette Reyes−Soffer: asbmb.org/asbmb-today/scienc….
Check out our new paper on racial disparities in patients with chronic liver disease and Covid-19 publish in @AGA_Gastro! @renumathyd @sadebecks @LizzieAbyMD @KWegermann @RotonyaC
Carr-Lab retweeted
Introducing #AGAGivingDay social chairs: Follow @drfolamay @AustinChiangMD @RotonyaC @IBD_FloMD @DCharabaty to hear why they support research to end GI health disparities. You can join them by making a gift for #AGAGivingDay now through Dec. 3 ow.ly/UM2K50Caxj4 #EquityinGI

















